{
  "ID": 77503,
  "GUID": "87070872-69FF-4207-A2B6-43BBAE534C0E",
  "File": "Res 0080-2026",
  "Name": "Reschedule Marijuana as a Schedule III drug.",
  "Title": "Resolution calling on the federal government to reschedule Marijuana as a Schedule III drug",
  "TypeID": 1,
  "TypeName": "Resolution",
  "StatusID": 3,
  "StatusName": "Committee",
  "BodyID": 19,
  "BodyName": "Committee on Public Safety",
  "IntroDate": "2026-01-29T00:00:00Z",
  "AgendaDate": "2026-01-29T00:00:00Z",
  "PassedDate": "0001-01-01T00:00:00Z",
  "EnactmentDate": "0001-01-01T00:00:00Z",
  "Version": "*",
  "Sponsors": [
    {
      "ID": 7810,
      "Slug": "amanda-c-farias",
      "FullName": "Amanda C. Far√≠as"
    }
  ],
  "History": [
    {
      "ID": 432321,
      "Date": "2026-01-29T13:25:00Z",
      "ActionID": 27,
      "Action": "Introduced by Council",
      "Description": "This Resolution was Introduced by Council",
      "BodyID": 1,
      "BodyName": "City Council",
      "Version": "*",
      "MatterStatusID": 2,
      "LastModified": "2026-01-29T16:57:05.927Z"
    },
    {
      "ID": 433040,
      "Date": "2026-01-29T13:30:00Z",
      "ActionID": 43,
      "Action": "Referred to Comm by Council",
      "Description": "This Resolution was Referred to Comm by Council to the Committee on Public Safety",
      "BodyID": 1,
      "BodyName": "City Council",
      "EventID": 22173,
      "AgendaSequence": 383,
      "MinutesSequence": 392,
      "AgendaNumber": "~SPONSOR",
      "Version": "*",
      "AgendaNote": "Public Safety",
      "MatterStatusID": 3,
      "LastModified": "2026-02-09T19:18:37.447Z"
    }
  ],
  "Attachments": [
    {
      "ID": 336040,
      "LastModified": "2026-02-18T22:02:17.083Z",
      "Name": "Res. No. 80",
      "Link": "https://nyc.legistar1.com/nyc/attachments/ccd7a3c5-5b31-4824-b9a6-dfcac8fcbcb8.docx",
      "Sort": 1
    },
    {
      "ID": 334484,
      "LastModified": "2026-02-16T23:32:03.453Z",
      "Name": "January 29, 2026 - Stated Meeting Agenda",
      "Link": "https://nyc.legistar1.com/nyc/attachments/8922f208-ad83-448a-a1dc-e2dd07aa04b5.pdf",
      "Sort": 2
    },
    {
      "ID": 335175,
      "LastModified": "2026-02-16T23:40:21.327Z",
      "Name": "Hearing Transcript - Stated Meeting 1-29-26",
      "Link": "https://nyc.legistar1.com/nyc/attachments/217f9aa1-0bc8-4ba5-a48a-529171ccbc91.pdf",
      "Sort": 3
    }
  ],
  "Summary": "",
  "TextID": 81545,
  "Text": "Whereas, Marijuana is a Schedule I substance under the federal Controlled Substances Act, meaning that it has a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision; and\n      Whereas, Schedule III drugs, substances, or chemicals have a moderate to low potential for physical and psychological dependence, with abuse potential less than Schedule I and  II drugs; and\n      Whereas, Examples of Schedule I drugs include heroin, LSD, marijuana, ecstasy, methaqualone, and peyote, and examples of Schedule III drugs include Tylenol with codeine, ketamine, anabolic steroids, and testosterone; and\n      Whereas, The classification of marijuana as a Schedule I drug, notwithstanding the lack of recognition of the United States Food and Drug Administration, contradicts its widely recognized therapeutic benefits and growing acceptance for medical use in numerous states; and\n      Whereas, The Biden administration has proposed a landmark change in federal marijuana policy, aiming to reclassify marijuana under the Controlled Substances Act from Schedule I to Schedule III; and\n      Whereas, This proposed reclassification acknowledges the therapeutic benefits of marijuana and its potential as a medication for millions of Americans, according to the National Organization for the Reform of Marijuana Laws; and\n      Whereas, Experts argue that marijuana's placement on Schedule I lacked scientific basis and that reclassifying it to Schedule III could alleviate the burden on cannabis companies and align federal regulations with public opinion and medical consensus; and\n      Whereas, Reclassification of marijuana from Schedule I to Schedule III could encourage more doctors to recommend its use for medical purposes and could facilitate research into its medical benefits and expand treatment options for patients with various conditions; and\n      Whereas, Aligning federal drug scheduling classifications with scientific evidence and public opinion is essential for effective drug policy and public health; now, therefore, be it\n      Resolved, That the Council of the City of New York calls on the federal government to reschedule Marijuana as a Schedule III drug.\n      \nCMB\nLS #16856\nRes. #0439-2024\n1/2/2026 3:37 PM\n2",
  "RTF": "{\\rtf1\\fbidis\\ansi\\ansicpg1252\\deff0\\deflang1033\\deflangfe1033{\\fonttbl{\\f0\\froman\\fprq2\\fcharset0 Times New Roman;}}\n\\viewkind4\\uc1\n\\v0\\par\nBy Council Member Far\\'edas \\par\n\\par\n\\pard\\ltrpar\\fi720\\sa160\\sl480\\slmult1\\qj Whereas, Marijuana is a Schedule I substance under the federal Controlled Substances Act, meaning that it has a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision; and\\par\nWhereas, Schedule III drugs, substances, or chemicals have a moderate to low potential for physical and psychological dependence, with abuse potential less than Schedule I and  II drugs; and\\par\nWhereas, Examples of Schedule I drugs include heroin, LSD, marijuana, ecstasy, methaqualone, and peyote, and examples of Schedule III drugs include Tylenol with codeine, ketamine, anabolic steroids, and testosterone; and\\par\nWhereas, The classification of marijuana as a Schedule I drug, notwithstanding the lack of recognition of the United States Food and Drug Administration, contradicts its widely recognized therapeutic benefits and growing acceptance for medical use in numerous states; and\\par\nWhereas, The Biden administration has proposed a landmark change in federal marijuana policy, aiming to reclassify marijuana under the Controlled Substances Act from Schedule I to Schedule III; and\\par\nWhereas, This proposed reclassification acknowledges the therapeutic benefits of marijuana and its potential as a medication for millions of Americans, according to the National Organization for the Reform of Marijuana Laws; and\\par\nWhereas, Experts argue that marijuana\\rquote s placement on Schedule I lacked scientific basis and that reclassifying it to Schedule III could alleviate the burden on cannabis companies and align federal regulations with public opinion and medical consensus; and\\par\nWhereas, Reclassification of marijuana from Schedule I to Schedule III could encourage more doctors to recommend its use for medical purposes and could facilitate research into its medical benefits and expand treatment options for patients with various conditions; and\\par\nWhereas, Aligning federal drug scheduling classifications with scientific evidence and public opinion is essential for effective drug policy and public health; now, therefore, be it\\par\nResolved, That the Council of the City of New York calls on the federal government to reschedule Marijuana as a Schedule III drug.\\par\n\\pard\\ltrpar\\fi720\\sa160\\sl480\\slmult1\\par\n\\pard\\ltrpar\\fs20 CMB\\par\nLS #16856\\par\nRes. #0439-2024\\par\n1/2/2026 3:37 PM\\par\n}\n",
  "LastModified": "2026-02-18T22:02:27.173Z"
}
